C. Ann Merrifield, Director at JUNIPER PHARMACEUTICALS INC (JNP), bought 2,000 shares at $5.63 ($11K) on 2016-08-26, disclosed to the SEC on 2016-08-29.
Open-market purchase of $11k JNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| LYRA | BUY | 2021-06-22 | $31K | — | Filing → |
| FLXN | BUY | 2019-05-24 | $101K | — | Filing → |
| FLXN | BUY | 2016-06-16 | $13K | — | Filing → |